Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled, open‐label extension of a phase III study

INTRODUCTION: The aim of the present study was to assess the long‐term (52‐week) efficacy and safety of ipragliflozin in insulin‐treated Japanese patients with type 1 diabetes mellitus and inadequate glycemic control. MATERIALS AND METHODS: In this 28‐week, open‐label extension of a multicenter, ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Kohei, Isaka, Hiroyuki, Sakatani, Taishi, Toyoshima, Junko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232286/
https://www.ncbi.nlm.nih.gov/pubmed/31743569
http://dx.doi.org/10.1111/jdi.13181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232286/
https://www.ncbi.nlm.nih.gov/pubmed/31743569
http://dx.doi.org/10.1111/jdi.13181

Ejemplares similares